Phase III comparative study of KRP-108 -Open-label, active-controlled, crossover comparative study of KRP-108 in pediatric bronchial asthma-
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Formoterol/fluticasone propionate (Primary) ; Fluticasone propionate; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 03 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Aug 2017 Status changed from not yet recruiting to recruiting.
- 03 Jul 2017 New trial record